ProfileGDS4718 / 1561360_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 51% 50% 50% 51% 49% 52% 50% 50% 51% 49% 50% 50% 54% 48% 50% 51% 47% 52% 51% 50% 50% 49% 50% 48% 53% 50% 49% 48% 49% 49% 49% 52% 51% 49% 52% 48% 49% 50% 48% 50% 48% 52% 51% 50% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5634651
GSM549102patient 115, normal, homogenized [OPG study]5.5221850
GSM549104patient 119, normal, homogenized [OPG study]5.4869550
GSM549108patient 138, normal, homogenized [OPG study]5.5868151
GSM549119patient 077, normal, homogenized [OPG study]5.4734649
GSM549133patient 032, cancer, homogenized [OPG study]5.6040152
GSM549139patient 042, cancer, homogenized [OPG study]5.4814150
GSM549099patient 107, normal, homogenized [OPG study]5.5063650
GSM549109patient 139, normal, homogenized [OPG study]5.5725451
GSM549110patient 046, normal, homogenized [OPG study]5.4822849
GSM549114patient 063, normal, homogenized [OPG study]5.4836850
GSM549122patient 082, normal, homogenized [OPG study]5.5326350
GSM549134patient 033, cancer, homogenized [OPG study]5.7203754
GSM549136patient 036, cancer, homogenized [OPG study]5.3595348
GSM549140patient 044, cancer, homogenized [OPG study]5.5082350
GSM549111patient 047, normal, homogenized [OPG study]5.5717651
GSM549113patient 057, normal, homogenized [OPG study]5.2653947
GSM549132patient 031, cancer, homogenized [OPG study]5.5939852
GSM549137patient 038, cancer, homogenized [OPG study]5.5707651
GSM549142patient 047, cancer, homogenized [OPG study]5.6595350
GSM549100patient 110, normal, homogenized [OPG study]5.5177550
GSM549107patient 135, normal, homogenized [OPG study]5.4429749
GSM549115patient 068, normal, homogenized [OPG study]5.468150
GSM549116patient 072, normal, homogenized [OPG study]5.3768448
GSM549120patient 078, normal, homogenized [OPG study]5.6667253
GSM549131patient 030, cancer, homogenized [OPG study]5.4459350
GSM549118patient 074, normal, homogenized [OPG study]5.4493949
GSM549129patient 027, cancer, homogenized [OPG study]5.4231148
GSM549123patient 088, normal, homogenized [OPG study]5.4171549
GSM549124patient 006, cancer, homogenized [OPG study]5.4837549
GSM549126patient 015, cancer, homogenized [OPG study]5.4645549
GSM549128patient 025, cancer, homogenized [OPG study]5.6153952
GSM549103patient 117, normal, homogenized [OPG study]5.6252751
GSM549117patient 073, normal, homogenized [OPG study]5.4346949
GSM549138patient 041, cancer, homogenized [OPG study]5.6078952
GSM549141patient 045, cancer, homogenized [OPG study]5.3705348
GSM549130patient 028, cancer, homogenized [OPG study]5.4799549
GSM549101patient 111, normal, homogenized [OPG study]5.5346650
GSM549105patient 128, normal, homogenized [OPG study]5.4293448
GSM549106patient 134, normal, homogenized [OPG study]5.4668450
GSM549112patient 048, normal, homogenized [OPG study]5.4065448
GSM549125patient 011, cancer, homogenized [OPG study]5.6492852
GSM549127patient 024, cancer, homogenized [OPG study]5.6144851
GSM549135patient 035, cancer, homogenized [OPG study]5.4870250